JST [JINPAN INTERNATIONAL] 6-K: (Original Filing)
[JINPAN INTERNATIONAL LIMITED]
JFC [JPMORGAN CHINA REGION FUND,] DEFA14A: SCHEDULE 14A Check the appropriate box: [ ]
[SCHEDULE 14A Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Definitive Proxy Statement [X] Definitiveditional Materials JF China Region Fund, _______________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Feemputed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11]
JST [JINPAN INTERNATIONAL] 6-K: JINPAN INTERNATIONAL LIMITED
[JINPAN INTERNATIONAL LIMITED]
JKS [JinkoSolar] 20-F: (Original Filing)
[Longgen Zhang, Chief Financial Officer 1 Jingke Road STYLE="font-family:Times New Roman" SIZE="2"> Shangrao Economic Development Zone Jiangxi Province, 334100 Peoples Republic of China STYLE="font-family:Times New Roman" SIZE="2"> Tel: (86-793) 846-9699 Fax: (86-793) 846-1152 E-mail: longgen.zhang@jinkosolar.com STYLE="font-family:Times New Roman" SIZE="2"> (Name, Telephone, E-mail and/or Facsimile number anddress ofmpanyntact Person)] [CONFIDENTIAL AMENDMENT NO. 2 TO AMENDED& RESTATED SUPPLYREEMENT JINKO HOKU Party Parties ECITALS R Whereas, HOKU and JINKO desire to further amend certain provisions of thereement set forth herein to, among other things, reduce the price of polysilicon per kilogram for the first five (5)years, establish the pricing mechanism for the remaining four (4)years, andjust] [SIGNIFICANT SUBSIDIARIES OF JINKOSOLAR STYLE="font-family:Times New Roman" SIZE="2"> Paker Technology Limited,orporated in Hong Kongecialministrative Region of the Peoples Republic of China JinkoSolar International Limited,orporated in Hong Kongecialministrative Region of the Peoples Republic of China JinkoSolarorporated in Germany STYLE="font-family:Times New Roman" SIZE="2">Jiangxi Jinko Solarorporated in the Peoples Republic of China] [STYLE="font-family:Times New Roman" SIZE="2"> I, Kangping Chen, certify that: 1. I have reviewed this annual report on Form 20-F of JinkoSolar; 2. Based on my knowledge, this annual report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [STYLE="font-family:Times New Roman" SIZE="2"> I, Longgen Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of JinkoSolar; 2. Based on my knowledge, this annual report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [STYLE="font-family:Times New Roman" SIZE="2"> (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Kangping Chen Chief Executive Officer April 25, 2011 dex131.htm 6 EX-13.1] [STYLE="font-family:Times New Roman" SIZE="2"> (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Longgen Zhang Chief Financial Officer April 25, 2011 dex132.htm 7 EX-13.2]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)
[H UNTER T AUBMAN W EISS LLP Louis Taubman (Admitted NY) LTaubman@htwlaw.com Email: April 25, 2010 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, LESER HUNTER TAUBMAN & TAUBMAN Attorney at Law cc:]
JKS [JinkoSolar] 20-F: Longgen Zhang, Chief Financial Officer 1 Jingke Road
[Longgen Zhang, Chief Financial Officer 1 Jingke Road STYLE="font-family:Times New Roman" SIZE="2"> Shangrao Economic Development Zone Jiangxi Province, 334100 Peoples Republic of China STYLE="font-family:Times New Roman" SIZE="2"> Tel: (86-793) 846-9699 Fax: (86-793) 846-1152 E-mail: longgen.zhang@jinkosolar.com STYLE="font-family:Times New Roman" SIZE="2"> (Name, Telephone, E-mail and/or Facsimile number anddress ofmpanyntact Person)] [CONFIDENTIAL AMENDMENT NO. 2 TO AMENDED& RESTATED SUPPLYREEMENT JINKO HOKU Party Parties ECITALS R Whereas, HOKU and JINKO desire to further amend certain provisions of thereement set forth herein to, among other things, reduce the price of polysilicon per kilogram for the first five (5)years, establish the pricing mechanism for the remaining four (4)years, andjust] [SIGNIFICANT SUBSIDIARIES OF JINKOSOLAR STYLE="font-family:Times New Roman" SIZE="2"> Paker Technology Limited,orporated in Hong Kongecialministrative Region of the Peoples Republic of China JinkoSolar International Limited,orporated in Hong Kongecialministrative Region of the Peoples Republic of China JinkoSolarorporated in Germany STYLE="font-family:Times New Roman" SIZE="2">Jiangxi Jinko Solarorporated in the Peoples Republic of China] [STYLE="font-family:Times New Roman" SIZE="2"> I, Kangping Chen, certify that: 1. I have reviewed this annual report on Form 20-F of JinkoSolar; 2. Based on my knowledge, this annual report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [STYLE="font-family:Times New Roman" SIZE="2"> I, Longgen Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of JinkoSolar; 2. Based on my knowledge, this annual report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [STYLE="font-family:Times New Roman" SIZE="2"> (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Kangping Chen Chief Executive Officer April 25, 2011 dex131.htm 6 EX-13.1] [STYLE="font-family:Times New Roman" SIZE="2"> (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Longgen Zhang Chief Financial Officer April 25, 2011 dex132.htm 7 EX-13.2]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: H UNTER T AUBMAN W EISS LLP Louis
[H UNTER T AUBMAN W EISS LLP Louis Taubman (Admitted NY) LTaubman@htwlaw.com Email: April 25, 2010 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, LESER HUNTER TAUBMAN & TAUBMAN Attorney at Law cc:]
ZX [China Zenix Auto International] F-1/A: (Original Filing)
[CALCULATION OF REGISTRATION FEE Title of Each Class ofSecurities to be RegisteredSTYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(2) ProposedMaximumAggregate (4) Amountof Ordinary shares, par value US$0.0001 per ordinary share US$250,000,000 US$29,025 (1) American depositary shares issuable upon deposit of the ordinary shares registered hereby will be registered under a separate registration statement on Form F-6 (Registration No.333-173588). Each American] [DEED OFNFIRMATION STYLE="font-family:Times New Roman" SIZE="2"> This DEED BETWEEN: (1) NEWRACE LIMITED Newrace (2) RICHBURGS LIMITED Richburg RECITALS (A) Shareholdersreement Newrace and Richburg entered into a share subscription and shareholdersreementted 10August 2008 (the (B) Supplemental Shareholdersreement Newrace, Richburg and Ms.Laifan Chu entered into a supplementaryreementted 12August 2008 (the] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM STYLE="font-family:Times New Roman" SIZE="2"> Wesonsent to the reference to us under the heading Selectednsolidated Financialta and Experts in such Prospectus. Hong Kong April 25, 2011NSENT OF DELOITTE TOUCH TOHMATSU dex231.htm 3 EX-23.1]
ZX [China Zenix Auto International] F-1/A: CALCULATION OF REGISTRATION FEE Title of Each Class
[CALCULATION OF REGISTRATION FEE Title of Each Class ofSecurities to be RegisteredSTYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(2) ProposedMaximumAggregate (4) Amountof Ordinary shares, par value US$0.0001 per ordinary share US$250,000,000 US$29,025 (1) American depositary shares issuable upon deposit of the ordinary shares registered hereby will be registered under a separate registration statement on Form F-6 (Registration No.333-173588). Each American] [DEED OFNFIRMATION STYLE="font-family:Times New Roman" SIZE="2"> This DEED BETWEEN: (1) NEWRACE LIMITED Newrace (2) RICHBURGS LIMITED Richburg RECITALS (A) Shareholdersreement Newrace and Richburg entered into a share subscription and shareholdersreementted 10August 2008 (the (B) Supplemental Shareholdersreement Newrace, Richburg and Ms.Laifan Chu entered into a supplementaryreementted 12August 2008 (the] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM STYLE="font-family:Times New Roman" SIZE="2"> Wesonsent to the reference to us under the heading Selectednsolidated Financialta and Experts in such Prospectus. Hong Kong April 25, 2011NSENT OF DELOITTE TOUCH TOHMATSU dex231.htm 3 EX-23.1]
